• Recognizes the potential of MH002 to address a serious medical condition with high unmet need • Enables accelerated development and increased FDA interactions to streamline review process • MRM Health will be presenting at upcoming Digestive Disease Week (DDW) 2026,...
Read the full article below. MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline 4 September, 2025 – Ghent, Belgium MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based...
The European Microbiome Innovation for Health (EMIH) highly welcomes the initiative of the European Commission to propose a European Biotech Act. This emerging sector needs a proper regulatory framework to ensure patients’ safety and timely access to innovative...
Paris, France, June 10, 2025 – On March 18, 2025, the Microbiome Times Forum, co-organized by the Microbiome Times together with EMIH (European Microbiome Innovation for Health) and MTIG (Microbiome Therapeutics Innovation Group), opened its doors to +500...
Paris, France, June 5, 2025 – The European Microbiome Innovation for Health (EMIH) announced a significant expansion, welcoming 13 new members, including private companies, public organizations, and a European patient advocacy group to its coalition....
